ID   A9 [Mouse Lewis lung carcinoma]
AC   CVCL_S007
SY   3LL-A9; 3LL clone A9
DR   Wikidata; Q54607231
RX   PubMed=3855489;
RX   PubMed=6490207;
RX   PubMed=8425771;
CC   Characteristics: Low metastatic potential.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
RX   PubMed=3855489; DOI=10.1093/jnci/74.1.77;
RA   Eisenbach L., Segal S., Feldman M.;
RT   "Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in
RT   clones of Lewis lung carcinoma and T10 sarcoma.";
RL   J. Natl. Cancer Inst. 74:77-85(1985).
//
RX   PubMed=6490207; DOI=10.1002/ijc.2910340421;
RA   Eisenbach L., Hollander N., Greenfeld L., Yakor H., Segal S.,
RA   Feldman M.;
RT   "The differential expression of H-2K versus H-2D antigens,
RT   distinguishing high-metastatic from low-metastatic clones, is
RT   correlated with the immunogenic properties of the tumor cells.";
RL   Int. J. Cancer 34:567-573(1984).
//
RX   PubMed=8425771; DOI=10.1002/ijc.2910530224;
RA   Fitzer-Attas C., Feldman M., Eisenbach L.;
RT   "Expression of functionally intact PDGF-alpha receptors in highly
RT   metastatic 3LL Lewis lung carcinoma cells.";
RL   Int. J. Cancer 53:315-322(1993).
//